An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy and safety of higher doses of
monosialoganglioside GM1 injection in the treatment of patients with acute ischemic stroke.
Phase:
Phase 4
Details
Lead Sponsor:
General Hospital of Shenyang Military Region
Collaborator:
The Third Xiangya Hospital of Central South University